Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martin Coyne takes up advisory role at Urovalve

This article was originally published in Clinica

Executive Summary

Urovalve, a privately-held company specialising in disorders associated with urinary flow and control, has appointed a former senior executive at Kodak as senior business advisor. Martin Coyne spent 18 years at Eastman Kodak, where he held various management roles in sales, advertising, marketing and business development, according to Urovalve. He has served as chairman of diagnostic medical devices company Welch Allyn, and was a member of the executive committee of US medtech industry association AdvaMed. The Newark, New Jersey-based company is looking to benefit from Mr Coyne's "extensive experience" in the healthcare industry to grow its business – the firm is planning to initiate a pilot study this year of its Surinate bladder management system, a device designed for use by men who suffer from acute or chronic urinary retention.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel